TaiwanJ Pharmaceuticals Co., Ltd. (TPEX:6549)

TaiwanJ Pharmaceuticals Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Assets

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	67.82	47.61	58.83	60.69	82.88
Short-Term Investments	-	40	-	-	-
Cash & Short-Term Investments	67.82	87.61	58.83	60.69	82.88
Cash Growth	-22.58%	48.92%	-3.06%	-26.77%	-11.31%
Accounts Receivable	-	-	-	4.61	-
Other Receivables	5.37	5.31	4.85	5.68	5.26
Receivables	5.37	5.31	4.85	10.29	5.26
Prepaid Expenses	0.23	0.27	0.18	0.17	0.25
Other Current Assets	-	-	0.23	0.02	0
Total Current Assets	73.42	93.18	64.09	71.17	88.39
Property, Plant & Equipment	2.25	1.51	3.04	3.03	0.32
Other Intangible Assets	-	-	0.36	0.94	76.8
Other Long-Term Assets	1.58	6.08	6.08	4.65	4.83
Total Assets	77.25	100.77	73.56	79.79	170.33

Liabilities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accrued Expenses	3.46	4.15	4.5	4.45	5.16
Current Portion of Leases	0.78	0.47	0.7	0.69	0.33
Other Current Liabilities	1.08	1.09	0.95	1.88	1.36
Total Current Liabilities	5.32	5.71	6.15	7.02	6.85
Long-Term Leases	1.01	-	0.47	1.17	-
Total Liabilities	6.33	5.71	6.62	8.19	6.85

Shareholders' Equity

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	801.22	801.22	751.22	751.22	751.22
Additional Paid-In Capital	2.64	2.43	1.97	0.59	-
Retained Earnings	-732.94	-708.59	-686.25	-680.2	-587.74
Shareholders' Equity	70.92	95.05	66.94	71.6	163.48
Total Liabilities & Equity	77.25	100.77	73.56	79.79	170.33

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	1.79	0.47	1.17	1.86	0.33
Net Cash (Debt)	66.04	87.14	57.66	58.83	82.55
Net Cash Growth	-24.21%	51.12%	-1.99%	-28.73%	-10.81%
Net Cash Per Share	0.82	1.14	0.77	0.78	1.10
Filing Date Shares Outstanding	80.12	80.12	75.12	75.12	75.12
Total Common Shares Outstanding	80.12	80.12	75.12	75.12	75.12
Working Capital	68.11	87.47	57.94	64.16	81.54
Book Value Per Share	0.89	1.19	0.89	0.95	2.18
Tangible Book Value	70.92	95.05	66.58	70.67	86.69
Tangible Book Value Per Share	0.89	1.19	0.89	0.94	1.15
Machinery	4.14	3.86	3.86	2.83	2.83
Leasehold Improvements	1.64	1.64	1.64	1.23	2.56

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 13, 2026

Data Sources Report a data error